Dry Eye Post Surgery Update
DOI:
https://doi.org/10.17140/OOJ-2-e007Keywords:
refractive, homeostasis, symptomsAbstract
A number of studies have mentioned high incidence of asymptomatic dry eye syndrome before
cataract surgery and more specifically refractive surgery with Excimer Láser. Ocular surgeries
play an important role that can trigger or exacerbates this condition.1
According to the new definition in the DWES II Report: “Dry eye is a multifactorial
ocular surface disease, characterized by a tear film loss of homeostasis, accompanied by
ocular symptoms, in which tear film instability, hyperosmolarity, ocular surface inflammation
and damage and neurosensory abnormalities play etiological roles
References
Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013; 8: e78657. doi: 10.1371/journal.pone.0078657
Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification. Ocul Surf. 2017; 15(3): 276-283. doi: 10.1016/j.jtos.2017.05.008
Bron AJ, Tomlinson A, Foulks GN, Pepose JS, Baudouin C, Geerling G. Rethinking dry eye disease: A perspective on clinical implications. Ocular Surf. 2014; 12(Suppl 2): S1-S31. doi: 10.1016/j.jtos.2014.02.002
Montes-Mico R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg. 2007; 33: 1631-1635. doi: 10.1016/j.jcrs.2007.06.019
Horwath-Winter J, Berghold A, Schmut O, et al. Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol. 2003; 121(10): 1364-1368. doi: 10.1001/archopht.121.10.1364
Chotikavanich S, de Paiva CS, De Quan Li, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009; 50(7): 3203-3209. doi: 10.1167/iovs.08-2476
González-Mesa A, Moreno-Arrones JP, Ferrari D, Teus MA. Role of tear osmolarity in dry eye symptoms after cataract surgery. Am J Ophthalmol. 2016; 170: 128-132. doi: 10.1016/j.ajo.2016.08.002
Mohammadpour M, Mehrabi S, Hassanpoor N, Mirshahi R. Effects of adjuvant omega-3 fatty acid supplementation on dry eye syn-drome following cataract surgery: A randomized clinical trial. J Curr Ophthalmol. 2016: 29: 33-38. doi: 10.1016/j.joco.2016.05.006
Ong NH, Purcell TL, Roch-Levecq AC, et al. Epithelial healing and visual outcomes of patients using omega-3 oral nutri-tional supplements before and after photorefractive keratectomy: A pilot study. Cornea. 2013; 32(6): 761-765. doi: 10.1097/ ICO.0b013e31826905b3
He J, Bazan HE. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids. 2010; 82(4-6): 319-325. doi: 10.1016/j.plefa.2010.02.004
Mohammadpour M, Mehrabi S, Hassanpoor N, Mirshahi R. Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial. J Curr Ophthalmol. 2017; 29: 33-38. doi: 10.1016/j. joco.2016.05.006
Yusufu M, Liu X, Zheng T, Fan F, Xu J, Luo Y. Hydroxypropyl methylcelullose 2% for ry eye prevention during phacoemulsi-fication in senile and diabetic patients. Int Ophthalmol. doi: 10.1007/s10792-017-0590-7
Kawahara A, Utsunomiya T, Kato Y, Takayanagi Y. Comparison of effect of nepafenac and diclofenac ophthalmic solution on cornea, ter film, and ocular surface after cataract surgery: The results of a randomized trial. Clin Ophthalmol. 2016; 64; 10: 385-391. doi: 10.2147/OPTH.S101836
Dell S. Intense pulsed light for evaporative dry eye disease. Clin Opthalmol. 2017; 11: 1167-1173. doi: 10.2147/OPTH.S139894
Liu R, Rong B, Tu P, et al. Analysis of Citokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017; pil: S0002-9394(17)30375-6. doi: 10.1016/j.ajo.2017.08.021
Toyos R, McGill W, Briscoe D. Intensed pulsed light treatment for dry eye disease. Photomed Laser Surg. 2015; 33(1): 41-46. doi: 10.1089/pho.2014.3819
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in The Ophthalmology (TOOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.